Last reviewed · How we verify
Menotrophin
Menotrophin is a Small molecule drug developed by Ferring Pharmaceuticals. It is currently FDA-approved. Also known as: Menogon® HP, Menopur, hMG, highly purified menotrophin.
Menotrophin is a protein agonist that targets the Lutropin-choriogonadotropic hormone receptor, specifically acting as a luteinizing hormone/Choriogonadotropin receptor agonist. It is used to treat conditions such as infertility, isolated hypogonadotropic hypogonadism, Kallmann syndrome, and reproductive issues, often in conjunction with other treatments like human chorionic gonadotropin during in vitro fertilization (IVF) cycles.
At a glance
| Generic name | Menotrophin |
|---|---|
| Also known as | Menogon® HP, Menopur, hMG, highly purified menotrophin, Menopur® HP-hMG |
| Sponsor | Ferring Pharmaceuticals |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles (PHASE4)
- Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer. (PHASE3)
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) (PHASE3)
- Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome (PHASE2)
- Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin
- DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT (NA)
- Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin
- Ovarian Hyperstimulation and Fibrin Clot Properties. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Menotrophin CI brief — competitive landscape report
- Menotrophin updates RSS · CI watch RSS
- Ferring Pharmaceuticals portfolio CI
Frequently asked questions about Menotrophin
What is Menotrophin?
Who makes Menotrophin?
Is Menotrophin also known as anything else?
What development phase is Menotrophin in?
Related
- Manufacturer: Ferring Pharmaceuticals — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Menogon® HP, Menopur, hMG, highly purified menotrophin, Menopur® HP-hMG
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing